A new kind of cellular immunotherapy shows promise in preventing Alzheimer's-associated plaques from forming in the brain – ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...

Scientists have long searched for ways to treat Alzheimer’s disease, the most common form of dementia. Chief among these ...

Alzheimer's brain markers, such as tau and amyloid, manifest differently across diverse populations, calling for personalized dementia care.

Scientists at Washington University in St. Louis have engineered brain cells to hunt and destroy amyloid plaques, cutting toxic buildup by roughly half in aged mice with advanced Alzheimer’s-like ...

Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining ...

Researchers engineer CAR-astrocytes to target and remove amyloid plaques in Alzheimer’s, showing a 50% reduction in brain ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

Scientists show that lecanemab clears amyloid plaques by engaging microglia through its Fc fragment, defining the cellular program behind its therapeutic effect ...

A single treatment of viral vector-delivered CAR-A construct in mice with existing plaque saturation cut the amount of amyloid plaques in half.

Findings showed 91.7% of patients with positive results using Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test had amyloid plaques based on PET scan or CSF test results. The Food and Drug ...